克服耐药性障碍:对抗多药耐药病原体的斯福米辛联合治疗取得了进展
Yan Wu1,2,3, Jimin Li1,2, Fengling Qiao1,2
1College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Frontiers in microbiology
|December 4, 2025
概括
斯福米辛联合治疗对于打击抗菌素耐药性 (AMR) 是至关重要的. 这篇评论探讨了氏菌素 (phosfomycin).
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益严重的全球健康危机.
- 福斯福米是一种较古老的抗生素,对抗多药耐药 (MDR) 病原体表现出活性.
- 斯福米辛单一治疗导致抗药的快速发展,限制了其临床使用.
研究的目的:
- 审查相素耐药性的机制,包括等离子体介导基因.
- 评估福斯福米辛组合疗法的临床前和临床证据.
- 识别菌素组合的障碍,并提出对菌素组合的未来研究方向.
主要方法:
- 对抗菌和分子耐药机制的系统分析.
- 对各种组合治疗方案的临床前和临床数据的全面评估.
- 批判性地检查临床前模型和临床结果之间的翻译差距.
主要成果:
- 斯福米辛表现出独特的作用机制,但容易产生耐药性.
- 组合疗法 (例如,与β-乳酸盐,氨基糖化物) 显示出协同效应.
- 福斯福米辛组合有显著的前景,但临床翻译面临挑战.
结论:
- 合理的组合疗法对于保持和增强氏素对MDR感染的疗效至关重要.
- 需要进一步的研究来弥合临床前发现和临床应用之间的差距.
- 未来的策略包括PK/PD导向剂量,非抗生素辅助剂和改进的临床前模型.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Development of Antibiotic Resistance
1.2K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.2K
Pulmonary Tuberculosis V
527
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
527
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Antimicrobial Effectiveness
883
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
883
Antibiotic Selection
59.3K
Overview
59.3K


